Scientists

Scientists

For science to make the news in a rigorous and attractive way, good sources are needed. Because access to scientific knowledge is a citizen's right.

¿Qué me ofrece?

Help science make headlines with rigour and context. We’ll ask you for feedback on current events in your field and you can participate in the briefings we’ll organise. Need to prepare for an interview? Use our resources on science communication.

Icono
Cómo trabajamos

We’re on the lookout for controversial information about science and we will contact you for your analysis in your area. Do you want to be part of our sources? Contact us. We will not pass your contact details on to anyone else. You can find out more about how we work here.   

Título qué me ofrece
What we offer you
Título cómo trabajamos
How we work

Dust concentrations rose across much of Europe between 2012 and 2021

Concentrations of desert dust rose steadily across much of Europe between 2012 and 2021, according to a study published today in the journal Nature. This was despite the fact that particulate matter pollution from emissions had fallen as a result of regulations. The trend could be linked to changes in atmospheric circulation and desertification in North Africa. Some of the largest increases were recorded in southern Europe and the Mediterranean region, where levels are more than double those in the north of the continent. The authors warn that dust pollution could have an increasing impact on air quality and public health.

0

A study claims that patients who have suffered a heart attack have higher levels of micro- and nanoplastics in their blood

A study involving a small group of people, published in the European Heart Journal, has measured the levels of plastic in the blood supplying the heart in 61 patients with myocardial infarction, chronic ischaemic heart disease or normal coronary arteries. According to the data, microplastics and nanoplastics were detected in 84 per cent of patients who had suffered a heart attack, compared with 40 per cent of patients with chronic ischaemic heart disease and 32 per cent of those with normal coronary arteries. Those exposed to higher levels of air pollution and smokers were more likely to have microplastics in their blood.

 

0

Sugar has been detected in interstellar space by the radio telescopes at Yebes in Guadalajara and Pico Veleta in the Sierra Nevada

A team led by a Spanish researcher has identified, near the centre of the Milky Way, a type of sugar composed of four carbon atoms, known as erythrulose, which on Earth is found in raspberries and self-tanning products. This would suggest that complex and biologically relevant molecules can form in space. Ribose and glucose had previously been discovered in samples from meteorites and asteroids, but until now no sugar had been directly detected in the interstellar medium. The finding is published in Nature Astronomy.

0

Dementia is on the rise in several countries in Latin America and the Caribbean, according to a two-decade study

A new study reveals that the proportion of adults with dementia has risen significantly in Mexico, Peru and Puerto Rico over the last two decades, rising from one in ten older adults to almost one in six; a trend that runs counter to that seen in the US and other wealthy countries. Rates remained stable in Cuba and the Dominican Republic. The authors urge investment in prevention, dementia screening and care infrastructure. The study is published in JAMA Neurology.

0

Dementia risk factors vary across countries depending on social determinants

Most of what is known about dementia prevention comes from research carried out in wealthy countries. A new study of more than 214,000 people from 14 countries reveals that the most common modifiable risk factors for dementia vary greatly from one country to another, meaning that a one-size-fits-all approach to prevention will not work everywhere. The differences were striking: low educational attainment affected 85.6 % of people in China, but only 12 % in the United States; whilst a high body mass index affected 44.9 % of Americans, compared with just 13.3 % in India. Similar patterns were also observed across all regions, such as cardiovascular risks (high cholesterol and high blood pressure) and risk behaviours (smoking and drinking). The findings, presented today at the 2026 Alzheimer’s Association International Conference (AAIC) in London, are also published in the journal The Lancet Healthy Longevity.  

0

Most Spaniards believe that AI facilitates the spread of hoaxes, but almost a third use it to find out about science

A briefing organised by the SMC presented the findings of the second edition of the study “Scientific Misinformation in Spain 2026”, carried out by FECYT. Among other findings, the report highlights that the perception of scientific misinformation has become normalised in areas of great everyday relevance such as diet, the climate and health.
0

51.5 per cent of the Spanish population feel capable of spotting misinformation about science, but only 18.1 per cent believe others are capable of doing so

Conspiracy thinking, populist attitudes and passive news consumption are the factors that most contribute to the spread of science-related hoaxes. Furthermore, if we consider the emotions that misleading content provokes in us, our inclination to share it increases whilst our inclination to verify it decreases. The topics on which people believe they receive the most false messages relate to nutrition and wellbeing, climate change, medical treatments and vaccines. Although most people believe that AI facilitates the spread of hoaxes, almost a third use it to find out about science at least once a week. These are some of the findings of the 2026 Study on Scientific Disinformation in Spain, published today by FECYT as part of the IBERIFIER Plus project.
0

Despite weight loss, most obesity medications do not significantly improve quality of life, according to a study

An international team analyzed data from 262 clinical trials involving 100,000 people, which evaluated a total of 19 currently available obesity drugs, including GLP-1 analogs such as semaglutide and tirzepatide. Overall, the results indicate that, despite substantial weight loss, most of the drugs do not significantly improve quality of life, and few show cardiovascular benefits after one year of treatment. Furthermore, those that achieved greater weight loss were often associated with more side effects. The study is published in The BMJ.

0